|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 799 for Fgf23

<< First    < Previous  |  Next >    Last >>
0.054s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Gene
8074 | FGF23
Type: gene
Organism: human
•
•
•
•
•
Gene
100233219 | fgf23
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
170583 | Fgf23
Type: gene
Organism: rat
•
•
•
•
•
Gene
611773 | FGF23
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
747164 | FGF23
Type: gene
Organism: chimpanzee
•
•
•
•
•
Gene
530239 | FGF23
Type: gene
Organism: cattle
•
•
•
•
•
Gene
428104 | FGF23
Type: gene
Organism: chicken
•
•
•
•
•
Gene
494456 | fgf23
Type: gene
Organism: zebrafish
•
•
•
•
•
Gene
710643 | FGF23
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Protein Coding Gene
MGI:1891427 | Fgf23
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
Protein Domain
IPR028304 | FGF23
Type: Family
Description: Fibroblast growth factors (FGFs) [, ]are a family of multifunctional proteins, often referred to as 'promiscuous growth factors' due to their diverse actions on multiple cell types [, ]. FGFs are mitogens, which stimulate growth or differentiation of cells of mesodermal or neuroectodermal origin. The function of FGFs in developmental processes include mesoderm induction, anterior-posterior patterning, limb development, and neural induction and development. In mature tissues, they are involved in diverse processes including keratinocyte organisation and wound healing [, , , , , ]. FGF involvement is critical during normal development of both vertebrates and invertebrates, and irregularities in their function leads to a range of developmental defects [, , , ]. Fibroblast growth factors are heparin-binding proteins and interactions with cell-surface-associated heparan sulfate proteoglycans have been shown to be essential for FGF signal transduction. FGFs have internal pseudo-threefold symmetry (β-trefoil topology) []. There are currently over 20 different FGF family members that have been identified in mammals, all of which are structurally related signaling molecules [, ]. They exert their effects through four distinct membrane fibroblast growth factor receptors (FGFRs), FGFR1 to FGFR4 [], which belong to the tyrosine kinase superfamily. Upon binding to FGF, the receptors dimerize and their intracellular tyrosine kinase domains become active [].This entry represents fibroblast growth factor 23 (FGF23), which is secreted by osteoblasts and osteoclasts []. FGF23 acts on kidneys, where it decreases the expression of NPT2, a sodium-phosphate cotransporter in the proximal tubule []. FGF23 is responsible for phosphate metabolism, decreasing the reabsorption and increasing excretion of phosphate []. FGF23 is involved in the pathogenesis of three hypophosphatemic disorders; oncogenic osteomalacia (OOM), X-linked hypophosphatemia (XLH) and autosomal dominant hypophosphatemic rickets (ADHR). These conditions are characterised by hypophosphatemia, decreased renal phosphate reabsorption, normal or low serum calcitriol concentrations and defective skeletal mineralisation [, , ].
•
•
•
•
•
Publication
11062477 | J:65463
First Author: ADHR Consortium.
Year: 2000
Journal: Nat Genet
Title: Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.
Volume: 26
Issue: 3
Pages: 345-8
•
•
•
•
•
Publication
11276432 | J:67832
First Author: Ornitz DM
Year: 2001
Journal: Genome Biol
Title: Fibroblast growth factors.
Volume: 2
Issue: 3
Pages: REVIEWS3005
•
•
•
•
•
Publication
21985788 | J:178443
First Author: Faul C
Year: 2011
Journal: J Clin Invest
Title: FGF23 induces left ventricular hypertrophy.
Volume: 121
Issue: 11
Pages: 4393-408
•
•
•
•
•
Publication
16449303 | J:110579
First Author: Liu S
Year: 2006
Journal: Am J Physiol Endocrinol Metab
Title: Pathogenic role of Fgf23 in Hyp mice.
Volume: 291
Issue: 1
Pages: E38-49
•
•
•
•
•
Publication
18559986 | J:140067
First Author: Liu S
Year: 2008
Journal: Am J Physiol Endocrinol Metab
Title: Pathogenic role of Fgf23 in Dmp1-null mice.
Volume: 295
Issue: 2
Pages: E254-61
•
•
•
•
•
Publication
37943605 | J:345899
 
First Author: Courbon G
Year: 2023
Journal: JCI Insight
Title: FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice.
Volume: 8
Issue: 24
•
•
•
•
•
Publication
29718273 | J:262478
First Author: Meo Burt P
Year: 2018
Journal: Endocrinology
Title: FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
Volume: 159
Issue: 6
Pages: 2386-2396
•
•
•
•
•
Publication
31420162 | J:291415
First Author: Tamamura Y
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Notch signaling is involved in Fgf23 upregulation in osteocytes.
Volume: 518
Issue: 2
Pages: 233-238
•
•
•
•
•
Publication
25051439 | J:218346
First Author: Ichikawa S
Year: 2014
Journal: Endocrinology
Title: Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse.
Volume: 155
Issue: 10
Pages: 3891-8
•
•
•
•
•
Publication
19556340 | J:225037
First Author: Liu S
Year: 2009
Journal: Mol Endocrinol
Title: Novel regulators of Fgf23 expression and mineralization in Hyp bone.
Volume: 23
Issue: 9
Pages: 1505-18
•
•
•
•
•
Publication
17942069 | J:129885
First Author: Onishi T
Year: 2008
Journal: Arch Oral Biol
Title: Phex mutation causes overexpression of FGF23 in teeth.
Volume: 53
Issue: 2
Pages: 99-104
•
•
•
•
•
Publication
27871077 | J:324436
First Author: Umbach AT
Year: 2016
Journal: Kidney Blood Press Res
Title: Impact of Annexin A 7 Deficiency on FGF23 Plasma Concentrations.
Volume: 41
Issue: 6
Pages: 828-836
•
•
•
•
•
Publication
23187128 | J:194201
First Author: Smith RC
Year: 2012
Journal: J Clin Invest
Title: Circulating αKlotho influences phosphate handling by controlling FGF23 production.
Volume: 122
Issue: 12
Pages: 4710-5
•
•
•
•
•
Publication
32065590 | J:297941
First Author: Simic P
Year: 2020
Journal: J Clin Invest
Title: Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney.
Volume: 130
Issue: 3
Pages: 1513-1526
•
•
•
•
•
Publication
31801907 | J:285265
 
First Author: Xiao Z
Year: 2019
Journal: JCI Insight
Title: FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
Volume: 4
Issue: 23
•
•
•
•
•
Publication
24068282 | J:324434
First Author: Li Y
Year: 2013
Journal: Calcif Tissue Int
Title: FGF23 affects the lineage fate determination of mesenchymal stem cells.
Volume: 93
Issue: 6
Pages: 556-64
•
•
•
•
•
Publication
24434184 | J:206448
First Author: Andrukhova O
Year: 2014
Journal: EMBO J
Title: FGF23 promotes renal calcium reabsorption through the TRPV5 channel.
Volume: 33
Issue: 3
Pages: 229-46
•
•
•
•
•
Publication
24797667 | J:232068
First Author: Andrukhova O
Year: 2014
Journal: EMBO Mol Med
Title: FGF23 regulates renal sodium handling and blood pressure.
Volume: 6
Issue: 6
Pages: 744-59
•
•
•
•
•
Publication
27498418 | J:249256
 
First Author: Andrukhova O
Year: 2016
Journal: Mol Cell Endocrinol
Title: Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Volume: 436
Pages: 224-39
•
•
•
•
•
Publication
18984852 | J:145616
First Author: Bai X
Year: 2009
Journal: Am J Physiol Endocrinol Metab
Title: Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
Volume: 296
Issue: 1
Pages: E79-88
•
•
•
•
•
Publication
14966565 | J:88172
First Author: Shimada T
Year: 2004
Journal: J Clin Invest
Title: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
Volume: 113
Issue: 4
Pages: 561-8
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689424
Stage: TS24
Assay Id: MGI:6190268
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Fgf23
Detected: false
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190268
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Fgf23
Detected: false
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689419
Stage: TS19
Assay Id: MGI:6190268
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Fgf23
Detected: false
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689421
Stage: TS21
Assay Id: MGI:6190268
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Fgf23
Detected: false
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689426
Stage: TS26
Assay Id: MGI:6190268
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Fgf23
Detected: false
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190268
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Fgf23
Detected: false
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6172877
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190268
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Fgf23
Detected: false
Specimen Num: 7
•
•
•
•
•
Publication
28183805 | J:274617
First Author: Kaludjerovic J
Year: 2017
Journal: FASEB J
Title: Klotho expression in long bones regulates FGF23 production during renal failure.
Volume: 31
Issue: 5
Pages: 2050-2064
•
•
•
•
•
Publication
33475190 | J:324471
First Author: Daryadel A
Year: 2021
Journal: FASEB J
Title: Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage.
Volume: 35
Issue: 2
Pages: e21302
•
•
•
•
•
Publication
24302726 | J:324437
First Author: Kawai M
Year: 2014
Journal: J Biol Chem
Title: Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner.
Volume: 289
Issue: 3
Pages: 1457-66
•
•
•
•
•
Publication
23577141 | J:199936
First Author: Lindberg K
Year: 2013
Journal: PLoS One
Title: Arterial klotho expression and FGF23 effects on vascular calcification and function.
Volume: 8
Issue: 4
Pages: e60658
•
•
•
•
•
Publication
15869926 | J:123814
First Author: Yu X
Year: 2005
Journal: Bone
Title: Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Volume: 36
Issue: 6
Pages: 971-7
•
•
•
•
•
Publication
23038738 | J:192371
First Author: Karaplis AC
Year: 2012
Journal: Endocrinology
Title: Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice.
Volume: 153
Issue: 12
Pages: 5906-17
•
•
•
•
•
Publication
17174939 | J:117241
First Author: Fukuda T
Year: 2007
Journal: Biochem Biophys Res Commun
Title: FGF23 induces expression of two isoforms of NAB2, which are corepressors of Egr-1.
Volume: 353
Issue: 1
Pages: 147-51
•
•
•
•
•
Publication
25243481 | J:223412
First Author: Lysaght AC
Year: 2014
Journal: PLoS One
Title: FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice.
Volume: 9
Issue: 9
Pages: e107681
•
•
•
•
•
Publication
30830862 | J:288013
 
First Author: Clinkenbeard EL
Year: 2019
Journal: JCI Insight
Title: Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
Volume: 4
Issue: 4
•
•
•
•
•
Publication
22249518 | -
First Author: Quarles LD
Year: 2012
Journal: Nat Rev Endocrinol
Title: Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
Volume: 8
Issue: 5
Pages: 276-86
•
•
•
•
•
Publication
21346724 | -
 
First Author: Jüppner H
Year: 2011
Journal: Kidney Int Suppl
Title: Phosphate and FGF-23.
Issue: 121
Pages: S24-7
•
•
•
•
•
Publication
18310961 | -
First Author: Fukumoto S
Year: 2008
Journal: Intern Med
Title: Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
Volume: 47
Issue: 5
Pages: 337-43
•
•
•
•
•
Publication
11409890 | -
First Author: Bowe AE
Year: 2001
Journal: Biochem Biophys Res Commun
Title: FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.
Volume: 284
Issue: 4
Pages: 977-81
•
•
•
•
•
Publication
18346951 | J:136859
First Author: Hollberg K
Year: 2008
Journal: Bone
Title: Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Volume: 42
Issue: 6
Pages: 1111-21
•
•
•
•
•
Publication
23873717 | J:233246
First Author: Clinkenbeard EL
Year: 2014
Journal: J Bone Miner Res
Title: Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice.
Volume: 29
Issue: 2
Pages: 361-9
•
•
•
•
•
Publication
37256933 | J:336374
First Author: Aprile A
Year: 2023
Journal: Sci Transl Med
Title: Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia.
Volume: 15
Issue: 698
Pages: eabq3679
•
•
•
•
•
Publication
28900153 | J:256537
First Author: Slavic S
Year: 2017
Journal: Sci Rep
Title: Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload.
Volume: 7
Issue: 1
Pages: 11298
•
•
•
•
•
Publication
23443925 | J:196066
First Author: Touchberry CD
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.
Volume: 304
Issue: 8
Pages: E863-73
•
•
•
•
•
Publication
15885032 | J:117597
First Author: Inoue Y
Year: 2005
Journal: Biochem J
Title: Role of the vitamin D receptor in FGF23 action on phosphate metabolism.
Volume: 390
Issue: Pt 1
Pages: 325-31
•
•
•
•
•
Publication
26428657 | J:237599
First Author: Fan Y
Year: 2016
Journal: FASEB J
Title: Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
Volume: 30
Issue: 1
Pages: 428-40
•
•
•
•
•
Publication
36943390 | J:348888
 
First Author: Ovejero D
Year: 2023
Journal: J Clin Invest
Title: Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source.
Volume: 133
Issue: 9
•
•
•
•
•
Publication
25053401 | J:215598
First Author: Silswal N
Year: 2014
Journal: Am J Physiol Endocrinol Metab
Title: FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.
Volume: 307
Issue: 5
Pages: E426-36
•
•
•
•
•
Publication
22970174 | J:286318
First Author: Dai B
Year: 2012
Journal: PLoS One
Title: A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.
Volume: 7
Issue: 9
Pages: e44161
•
•
•
•
•
Publication
17099775 | J:117377
First Author: Masuyama R
Year: 2006
Journal: J Clin Invest
Title: Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Volume: 116
Issue: 12
Pages: 3150-9
•
•
•
•
•
Publication
24348262 | J:207518
First Author: Olauson H
Year: 2013
Journal: PLoS Genet
Title: Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.
Volume: 9
Issue: 12
Pages: e1003975
•
•
•
•
•
Publication
31758181 | J:287936
 
First Author: Matthias J
Year: 2020
Journal: Endocrinology
Title: Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation.
Volume: 161
Issue: 1
•
•
•
•
•
Publication
32729975 | J:307389
First Author: Bøllehuus Hansen L
Year: 2020
Journal: FASEB J
Title: Influence of FGF23 and Klotho on male reproduction: Systemic vs direct effects.
Volume: 34
Issue: 9
Pages: 12436-12449
•
•
•
•
•
Publication
15998839 | J:101456
First Author: Shimada T
Year: 2005
Journal: Am J Physiol Renal Physiol
Title: Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
Volume: 289
Issue: 5
Pages: F1088-95
•
•
•
•
•
Publication
33853949 | J:332456
 
First Author: Radhakrishnan K
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury.
Volume: 118
Issue: 16
•
•
•
•
•
Publication
38479224 | J:346441
 
First Author: Jung YS
Year: 2024
Journal: Redox Biol
Title: ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress.
Volume: 71
Pages: 103107
•
•
•
•
•
Publication
27035636 | J:232398
First Author: Murali SK
Year: 2016
Journal: PLoS Biol
Title: Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Volume: 14
Issue: 4
Pages: e1002427
•
•
•
•
•
Publication
23235154 | J:315922
First Author: Kawai M
Year: 2013
Journal: J Biol Chem
Title: FGF23 suppresses chondrocyte proliferation in the presence of soluble α-Klotho both in vitro and in vivo.
Volume: 288
Issue: 4
Pages: 2414-27
•
•
•
•
•
Publication
26235988 | J:324438
First Author: Murali SK
Year: 2016
Journal: J Bone Miner Res
Title: FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner.
Volume: 31
Issue: 1
Pages: 129-42
•
•
•
•
•
Publication
28425622 | J:312342
First Author: Kamiya N
Year: 2017
Journal: J Bone Miner Res
Title: Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
Volume: 32
Issue: 8
Pages: 1716-1726
•
•
•
•
•
Publication
24259513 | J:206158
First Author: Gattineni J
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Volume: 306
Issue: 3
Pages: F351-8
•
•
•
•
•
Publication
22615579 | J:185208
First Author: Wang X
Year: 2012
Journal: PLoS Genet
Title: Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.
Volume: 8
Issue: 5
Pages: e1002708
•
•
•
•
•
Publication
29073196 | J:246521
First Author: Flamme I
Year: 2017
Journal: PLoS One
Title: FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase.
Volume: 12
Issue: 10
Pages: e0186979
•
•
•
•
•
Publication
33150413 | J:298845
 
First Author: Sellars KB
Year: 2021
Journal: Endocrinology
Title: Murine Fetal Serum Phosphorus is Set Independent of FGF23 and PTH, Except in the Presence of Maternal Phosphate Loading.
Volume: 162
Issue: 1
•
•
•
•
•
Publication
25007710 | J:215638
 
First Author: Reilly AM
Year: 2014
Journal: Bone
Title: Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.
Volume: 67
Pages: 139-44
•
•
•
•
•
Publication
19966287 | J:156501
First Author: Goetz R
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
Volume: 107
Issue: 1
Pages: 407-12
•
•
•
•
•
Publication
28794403 | J:309449
First Author: Sakurai A
Year: 2017
Journal: Biomed Res
Title: Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone.
Volume: 38
Issue: 4
Pages: 257-267
•
•
•
•
•
Protein
Q9EPC2
Organism: Mus musculus/domesticus
Length: 251  
Fragment?: false
•
•
•
•
•
Protein
Q3U1V5
Organism: Mus musculus/domesticus
Length: 251  
Fragment?: false
•
•
•
•
•
Protein
Q0VBJ8
Organism: Mus musculus/domesticus
Length: 251  
Fragment?: false
•
•
•
•
•
Publication
22370560 | J:197702
First Author: Wu X
Year: 2012
Journal: J Mol Biol
Title: A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Volume: 418
Issue: 1-2
Pages: 82-9
•
•
•
•
•
Publication
22647968 | J:192420
First Author: Andrukhova O
Year: 2012
Journal: Bone
Title: FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway.
Volume: 51
Issue: 3
Pages: 621-8
•
•
•
•
•
Publication
29635291 | J:261402
First Author: Liu ES
Year: 2018
Journal: Endocrinology
Title: Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
Volume: 159
Issue: 5
Pages: 2165-2172
•
•
•
•
•
Publication
31097591 | J:276542
First Author: Takashi Y
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation.
Volume: 116
Issue: 23
Pages: 11418-11427
•
•
•
•
•
Publication
22294750 | J:183813
First Author: Streicher C
Year: 2012
Journal: Endocrinology
Title: Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
Volume: 153
Issue: 4
Pages: 1795-805
•
•
•
•
•
Publication
38066669 | J:350137
 
First Author: Yadav PS
Year: 2023
Journal: Endocrinology
Title: Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.
Volume: 165
Issue: 1
•
•
•
•
•
Publication
33731726 | J:304841
First Author: Egli-Spichtig D
Year: 2021
Journal: Sci Rep
Title: Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
Volume: 11
Issue: 1
Pages: 6175
•
•
•
•
•
Publication
24601885 | J:210730
First Author: Ma Y
Year: 2014
Journal: Endocrinology
Title: Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.
Volume: 155
Issue: 5
Pages: 1596-605
•
•
•
•
•
Publication
22031097 | J:329780
First Author: Stubbs JR
Year: 2012
Journal: J Bone Miner Res
Title: Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
Volume: 27
Issue: 1
Pages: 38-46
•
•
•
•
•
Publication
37417950 | J:348467
First Author: Li X
Year: 2023
Journal: Blood Adv
Title: Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia.
Volume: 7
Issue: 17
Pages: 5156-5171
•
•
•
•
•
Publication
19933269 | J:159949
First Author: Xiao L
Year: 2010
Journal: J Biol Chem
Title: Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Volume: 285
Issue: 4
Pages: 2834-46
•
•
•
•
•
Publication
27929669 | J:246176
First Author: Ma Y
Year: 2017
Journal: Endocrinology
Title: FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.
Volume: 158
Issue: 2
Pages: 252-263
•
•
•
•
•
Publication
22930691 | J:225089
First Author: Martin A
Year: 2012
Journal: Mol Endocrinol
Title: Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Volume: 26
Issue: 11
Pages: 1883-95
•
•
•
•
•
Publication
19213845 | J:151805
First Author: Ichikawa S
Year: 2009
Journal: Endocrinology
Title: Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
Volume: 150
Issue: 6
Pages: 2543-50
•
•
•
•
•
Publication
19515808 | J:150719
First Author: Gattineni J
Year: 2009
Journal: Am J Physiol Renal Physiol
Title: FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
Volume: 297
Issue: 2
Pages: F282-91
•
•
•
•
•
Publication
26751835 | J:323234
First Author: Liu ES
Year: 2016
Journal: J Bone Miner Res
Title: 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
Volume: 31
Issue: 5
Pages: 929-39
•
•
•
•
•
Publication
17848631 | J:129380
First Author: Liu S
Year: 2007
Journal: Am J Physiol Endocrinol Metab
Title: Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Volume: 293
Issue: 6
Pages: E1636-44
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom